AI assistant
Sending…
Roivant Sciences Ltd. — Director's Dealing 2022
Dec 10, 2022
30587_dirs_2022-12-09_9a40f2ce-962b-43d9-bc39-8370a3df22ce.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Roivant Sciences Ltd. (ROIV)
CIK: 0001635088
Period of Report: 2022-12-08
Reporting Person: Venker Eric (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2022-12-08 | Common Shares | S | 11729 | $7 | Disposed | 1022118 | Direct |
| 2022-12-09 | Common Shares | S | 133376 | $7.03 | Disposed | 888742 | Direct |
Footnotes
F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 15, 2022.
More from Roivant Sciences Ltd.
Regulatory Filings
2026
May 20
Annual Report
2026
May 20
Regulatory Filings
2026
May 20
Regulatory Filings
2026
Apr 2
Major Shareholding Notification
2026
Mar 27
Director's Dealing
2026
Mar 25
Director's Dealing
2026
Mar 25
Regulatory Filings
2026
Mar 23
Director's Dealing
2026
Mar 19
Director's Dealing
2026
Mar 18